A tiny pharmacy raises big doubts about our drugs
The escalating global recall of Zantac, the heartburn pill that once ranked as the world's best-selling drug, has its roots not in government oversight or a high-profile lawsuit, but in...
Home > Reviews
All Stories
Pfizer sues Johnson & Johnson, alleging anticompetitive practices to maintain a drug monopoly
A legal brawl between two of the world's largest drug companies could shape the future of a nascent market of copycat drugs that are intended to bring down the cost...
Business group warns Republican health-care bill could cost companies
A leading business coalition has warned that employers could pick up the tab if millions of people lose their coverage under the Republican plan to repeal the Affordable Care Act....
Iowa’s last major Obamacare insurer says continued participation ‘is in question’
Iowa's last major Affordable Care Act insurer threatened on Wednesday to pull out from the state's marketplace next year, the latest step in a sudden collapse of the state's insurance...
It’s not the weather that makes Christmas so deadly
Every winter, deaths from heart-related conditions rise in the United States. Plotted on a graph, the rise in deaths looks like a hill - with two spikes at the top...
Mylan’s EpiPen profits are 60 percent more than it told Congress, report says
Lawmakers were skeptical last week when Mylan chief executive Heather Bresch said that the company made only $100 in profit for a two-pack of EpiPens. During a House hearing, Bresch...
Botox-maker Allergan takes on pharma’s pricing problem — a ‘festering wound’
Allergan, the pharmaceutical company best known for making Botox, pledged Tuesday to limit annual price increases on its drugs and to stop hiking prices on medicines right before their patents...
How Theranos’ reboot could backfire
Theranos chief executive Elizabeth Holmes tried to kick off the beleaguered company's comeback story on Monday in front of a few thousand scientists and doctors. She called the moment an...
Theranos chief pitches new blood-testing device amid caution
With her controversial blood-testing company under intense federal scrutiny, Theranos chief executive Elizabeth Holmes took the stage before hundreds of medical laboratory experts Monday to present a new blood-testing device...
Embattled Theranos chief plans to reveal science behind ‘groundbreaking’ technology, amid skepticism
It's finally arrived: a moment of truth for Theranos, the blood-testing company that was going to change the world with a technology that it has refused to explain - until...